Neurotoxicity of the anticoagulant-selective E149A-activated protein C variant after focal ischemic stroke in mice

Blood Cells, Molecules, and Diseases

Volumn 51, Issue 2, 2013, Pages 104-108

  Wang, Yaoming ^a   Sinha, Ranjeet Kumar ^b   Mosnier, Laurent O ^b   Griffin, John H ^b   Zlokovic, Berislav V ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Activated protein C; Ischemia; Mouse; Stroke

Indexed keywords

ACTIVATED PROTEIN C; HEMOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CELL PROTECTION; CONTROLLED STUDY; FORELIMB; HEMISPHERE; HEMOGLOBIN BLOOD LEVEL; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK; WILD TYPE;

ANIMALS; ANTICOAGULANTS; BEHAVIOR, ANIMAL; BRAIN; BRAIN ISCHEMIA; GENETIC VARIATION; HEMOGLOBINS; MALE; MICE; NEUROPROTECTIVE AGENTS; PROTEIN C; REPERFUSION INJURY; STROKE;

MURINAE; MUS;

EID: 84878392339     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2013.02.009     Document Type: Article

References (32)

1. Mosnier L.O., Zlokovic B.V., Griffin J.H. The cytoprotective protein C pathway. Blood 2007, 109:3161-3172.
2. Griffin J.H., Zlokovic B.V., Mosnier L.O. Protein C anticoagulant and cytoprotective pathways. Int. J. Hematol. 2012, 95:333-345.
3. Zlokovic B.V., Griffin J.H. Cytoprotective protein C pathways and implications for stroke and neurological disorders. Trends Neurosci. 2011, 34:198-209.
4. Griffin J.H., Fernández J.A., Mosnier L.O., Liu D., Cheng T., Guo H., Zlokovic B.V. The promise of protein C. Blood Cells Mol. Dis. 2006, 36:211-216.
5. Gale A.J., Tsavaler A., Griffin J.H. Molecular characterization of an extended binding site for coagulation factor Va in the positive exosite of activated protein C. J. Biol. Chem. 2002, 277:28836-28840.
6. Mosnier L.O., Gale A.J., Yegneswaran S., Griffin J.H. Activated protein C variants with normal cytoprotective but reduced anticoagulant activity. Blood 2004, 104:1740-1744.
7. Mosnier L.O., Yang X.V., Griffin J.H. Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin activated fibrinolysis inhibitor-dependent cytoprotective functions. J. Biol. Chem. 2007, 282:33022-33033.
8. Guo H., Singh I., Wang Y., Deane R., Barrett T., Fernández J.A., Chow N., Griffin J.H., Zlokovic B.V. Neuroprotective activities of activated protein C mutant with reduced anticoagulant activity. Eur. J. Neurosci. 2009, 29:1119-1130.
9. Guo H., Wang Y., Singh I., Liu D., Fernández J.A., Griffin J.H., Chow N., Zlokovic B.V. Species-dependent neuroprotection by activated protein C mutants with reduced anticoagulant activity. J. Neurochem. 2009, 109:116-124.
10. Wang Y., Zhang Z., Chow N., Davis T.P., Griffin J.H., Chopp M., Zlokovic B.V. An activated protein C analog with reduced anticoagulant activity extends the therapeutic window of tissue plasminogen activator for ischemic stroke in rodents. Stroke 2012, 43:2444-2449.
11. Mosnier L.O., Sinha R.K., Burnier L., Bouwens E.A., Griffin J.H. Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46. Blood 2012, 120:5237-5246.
12. Mosnier L.O., Zampolli A., Kerschen E.J., Schuepbach R.A., Banerjee Y., Fernández J.A., Yang X.V., Riewald M., Weiler H., Ruggeri Z.M., Griffin J.H. Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant. Blood 2009, 113:5970-5978.
13. Geiger H., Pawar S.A., Kerschen E.J., Nattamai K.J., Hernandez I., Liang H.P., Fernández J.A., Cancelas J.A., Ryan M.A., Kustikova O., Schambach A., Fu Q., Wang J., Fink L.M., Petersen K.U., Zhou D., Griffin J.H., Baum C., Weiler H., Hauer-Jensen M. Pharmacological targeting of the thrombomodulin-activated protein C pathway mitigates radiation toxicity. Nat. Med. 2012, 18:1123-1129.
14. Kerschen E.J., Fernandez J.A., Cooley B.C., Yang X.V., Sood R., Mosnier L.O., Castellino F.J., Mackman N., Griffin J.H., Weiler H. Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J. Exp. Med. 2007, 204:2439-2448.
15. van Bruggen N., Thibodeaux H., Palmer J.T., Lee W.P., Fu L., Cairns B., Tumas D., Gerlai R., Williams S.P., van Lookeren Campagne M., Ferrara N. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J. Clin. Invest. 1999, 104:1613-1620.
16. Hoang S., Liauw J., Choi M., Guzman R.G., Steinberg G.K. Netrin-4 enhances angiogenesis and neurologic outcome after cerebral ischemia. J. Cereb. Blood Flow Metab. 2009, 29:385-397.
17. Zlokovic B.V., Zhang C., Liu D., Fernandez J.A., Griffin J.H., Chopp M. Functional recovery after embolic stroke in rodents by activated protein C. Ann. Neurol. 2005, 58:474-477.
18. Wang Y., Thiyagarajan M., Chow N., Singh I., Guo H., Davis T.P., Zlokovic B.V. Differential neuroprotection and risk for bleeding from activated protein C with varying degrees of anticoagulant activity. Stroke 2009, 40:1864-1869.
19. Cheng T., Liu D., Griffin J.H., Fernandez J.A., Castellino F., Rosen E.D., Fukudome K., Zlokovic B.V. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat. Med. 2003, 9:338-342.
20. Gong Y., Hua Y., Keep R.F., Hoff J.T., Xi G. Intracerebral hemorrhage: effects of aging on brain edema and neurological deficits. Stroke 2004, 35:2571-2575.
21. Liu D., Cheng T., Guo H., Fernandez J.A., Griffin J.H., Song X., Zlokovic B.V. Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C. Nat. Med. 2004, 10:1379-1383.
22. Wang Y., Kilic E., Kilic U., Weber B., Bassetti C.L., Marti H.H., Hermann D.M. VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain 2005, 128:52-63.
23. Choudhri T.F., Hoh B.L., Solomon R.A., Connolly E.S., Pinsky D.J. Use of a spectrophotometric hemoglobin assay to objectively quantify intracerebral hemorrhage in mice. Stroke 1997, 28:2296-2302.
24. Cheng T., Petraglia A.L., Li Z., Thiyagarajan M., Zhong Z., Wu Z., Liu D., Maggirwar S.B., Deane R., Fernandez J.A., LaRue B., Griffin J.H., Chopp M., Zlokovic B.V. Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage. Nat. Med. 2006, 12:1278-1285.
25. Kerschen E., Hernandez I., Zogg M., Jia S., Hessner M.J., Fernandez J.A., Griffin J.H., Huettner C.S., Castellino F.J., Weiler H. Activated protein C targets CD8+ dendritic cells to reduce the mortality of endotoxemia in mice. J. Clin. Invest. 2010, 120:3167-3178.
26. Bir N., Lafargue M., Howard M., Goolaerts A., Roux J., Carles M., Cohen M.J., Iles K.E., Fernández J.A., Griffin J.H., Pittet J.F. Cytoprotective-selective activated protein C attenuates Pseudomonas aeruginosa-induced lung injury in mice. Am. J. Respir. Cell Mol. Biol. 2011, 45:632-641.
27. Zhong Z., Ilieva H., Hallagan L., Bell R., Singh I., Paquette N., Thiyagarajan M., Deane R., Fernandez J.A., Lane S., Zlokovic A.B., Liu T., Griffin J.H., Chow N., Castellino F.J., Stojanovic K., Cleveland D.W., Zlokovic B.V. Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells. J. Clin. Invest. 2009, 119:3437-3449.
28. Walker C.T., Marky A.H., Petraglia A.L., Ali T., Chow N., Zlokovic B.V. Activated protein C analog with reduced anticoagulant activity improves functional recovery and reduces bleeding risk following controlled cortical impact. Brain Res. 2010, 6:125-131.
29. Sen P., Clark C.A., Gopalakrishnan R., Hedner U., Esmon C.T., Pendurthi U.R., Rao L.V. Factor VIIa binding to endothelial cell protein C receptor: differences between mouse and human systems. Thromb. Haemost. 2012, 107:951-961.
30. Macko R.F., Killewich L.A., Fernández J.A., Cox D.K., Gruber A., Griffin J.H. Brain-specific protein C activation during carotid artery occlusion in humans. Stroke 1999, 30:542-545.
31. Lu X., Tang L., Xu K., Ma J., Guo T., Mei H., Yang R., Yu J., Wang Q., Yang Y., Jian X., Hu Y. Novel association of a PROC variant with ischemic stroke in a Chinese Han population. Hum. Genet. 2013, 132:69-77.
32. Mesters R.M., Heeb M.J., Griffin J.H. A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va. Biochemistry 1993, 32:12656-12663.